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a b s  t r  a c  t
Skin wounds  have  signiﬁcant  morbidity and  mortality  rates  associated.  This  is  explained  by the  limited
effectiveness  of the currently  available  treatments,  which  in some cases  do not allow  the  reestablish-
ment  of the  structure  and  functions  of the  damaged  skin,  leading  to  wound  infection  and dehydration.
These  drawbacks  may have  an  impact  on the  healing process  and  ultimately  prompt patients’  death.  For
this reason,  researchers are  currently developing  new  wound  dressings that enhance  skin  regeneration.
Among  them,  electrospun polymeric  nanoﬁbres have been  regarded  as promising  tools for improving
skin  regeneration  due to their  structural  similarity  with  the  extracellular  matrix  of normal skin,  capacity
to  promote  cell growth and proliferation  and bactericidal  activity as well as  suitability  to deliver  bioactive
molecules  to the wound site. In  this  review, an overview of  the recent  studies concerning  the production
and  evaluation of electrospun polymeric  nanoﬁbrous  membranes for skin  regenerative purposes  is pro-
vided.  Moreover,  the current  challenges  and  future  perspectives of electrospun  nanoﬁbrous  membranes
suitable  for this biomedical  application  are highlighted.
© 2018 Elsevier  B.V. All  rights reserved.
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1. Introduction
Electrospun nanoﬁbres have been applied in the biomedical
ﬁeld, as drug delivery systems [1–3] as well as 3D constructs for
tissue regeneration of  cartilage [4],  bone [5],  heart valves [6,7],  mus-
cle [8,9],  neural tissue [10] and skin [11,12] (see Fig. 1 for further
details).
When a skin injury occurs, it  is extremely important to re-
establish, as quickly as possible, the skin’s structure and functions
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